Finzati - Logo
NVAX logo

Novavax, Inc.

NVAX • Biotechnology
$10.22
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.68B
Growth
13.1%
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 39.2%Positive revenue growth · 27.1%Reasonable earnings multiple · 2.47Healthy liquidity · 2.13
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:09 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$10.22
Change0.00%
Shares Out164.57M
Market Cap$1.68B
Enterprise Value$1.26B
52W Range6.20 - 11.97
Beta2.43
P/E-6.79
P/S4.06
P/B-8.82
P/FCF-41.03
EV/Sales3.04

Investment DNA

How strong this company looks for long-term investors

80
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Stable or improving margins · 39.2%Positive revenue growth · 27.1%Reasonable earnings multiple · 2.47Healthy liquidity · 2.13

Analyst view

Analyst sentiment and price target

NVAX
Analyst sentiment
Based on 23 analyst votes · 2026-09-05
80/100
Bullish
Bullish
17
Hold
3
Bearish
3
Price Target
2026-08-07
Low
$11.00
Mean
$18.00
Median
$18.00
High
$25.00

Company Overview

IPO: 12/5/1995
Industry: Biotechnology
P/B i: -8.82
Debt / Equity i: -1.95
Operating Margin: 50.14%
Net Margin: 39.19%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: -1.95
Current Ratio: 2.13
Quick Ratio: 2.10
Status: Strong

Insider Transactions

Recent executive and insider activity

Alton Gregg H
Transaction: 06/20/2026
SELL
Change
-18,880
Price
Not reported
Filing
06/23/2026
Type
SELL
Alton Gregg H
Transaction: 06/20/2026
BUY
Change
+18,880
Price
Not reported
Filing
06/23/2026
Type
BUY
MOTT DAVID M
Transaction: 06/20/2026
SELL
Change
-18,880
Price
Not reported
Filing
06/23/2026
Type
SELL